Admission Date:  [**2153-6-6**]              Discharge Date:   [**2153-6-11**]  Date of Birth:  [**2079-7-7**]             Sex:   M  Service: MEDICINE  Allergies: Nsaids  Attending:[**First Name3 (LF) 5552**] Chief Complaint: N/V  Major Surgical or Invasive Procedure: EGD   History of Present Illness: HPI (per [**Hospital Unit Name 153**] admission note): 73 yo M h/o MDS x 10 yrs, TURP [**2141**], with Grade I T3N1b pancreatic adenocarcinoma discovered incidentally on CT scan in early [**2153**] now s/p partial pancreatectomy and total splenectomy on [**2153-3-13**] who was sent in from clinic [**6-6**] for anemia.
Had been feeling well recently - since partial pancreatectomy in late [**Month (only) 956**] he has gained 7 lbs, still working as a tax attorney.
For 6 weeks he has been receiving XRT and xeloda, both of which have been well tolerated without N/V/D/constipation, skin changes, mucositis.
He has been receiving Procrit weekly since [**Month (only) 462**] and went in for his weekly shot on the day of admission when he was found to have a HCT of 16.
No dysphagia, no skin changes with XRT, no abd pain s/p surgery nor with XRT.
In [**Month (only) **] he developed DM and treated with oral antihyperglycemics.
On [**2153-3-13**], he was taken to the OR for a partial pancreatectomy and splenectomy; path revealed pancreatic adenocarcinoma Grade I with margins that were not clear, T3N1b ([**3-11**] nodes positive).
The surgery was uncomplicated and the pt did well therafter.
He has been treated with a 6 week course of Xeloda and XRT.
Ring sideroblastic anemia/ MDS diagnosed in the early [**2137**] by bone marrow biopsy: The patient had been treated only with vitamin B-6, was never transfused and had no complications.
Status post transurethral resection of prostate in [**2141**] for benign prostatic hypertrophy.
Gout: The patient had one flare in [**2147-4-15**] to the right ankle, which was his only episode and he was then on allopurinol for quite some time.
Status post back surgery in [**2127**].
Midbody Pancreatic Mass s/p subtotal pancreatectomy in [**2153-3-13**] - presently receiving Xeloda and radiation therapy under the direction of Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] 8.
Splenectomy in [**2153-3-13**] for massive splenomegaly 9.
A red-to-maroon colored clot was situated within it.
Four cc of epinephrine at a concentration of 1:10,000 was injected around the vessel with good hemostasis.
[**Hospital1 **]-CAP Electrocautery was applied for hemostasis successfully.
Six cc of epinephrine at a concentration of 1:10,000 was injected for hemostasis with success.
Brief Hospital Course: 73 yo M h/o MDS, s/p recent partial pancreatectomy for mass and splenectomy for splenomegaly, who was admitted for melanotic stools and decreased HCT.
Pt was admitted to the ICU initially, then underwent injection and thermal therapy during the EGD.
- pt required 6 U PRBC's during the admission - hct stabilized prior to discharge, although pt continued to have guaiac + stools - pt was mande NPO initially, then tolerated regular diet prior to discharge - H. pylori Ab was negative - Pt should not have NSAIDs due to high risk of lesions rebleeding - pt was placed initially on IV protonix [**Hospital1 **], then swithced to PO protonix [**Hospital1 **].
Pt should continue protonix 40 mg PO twice a day for 8 weeks, and then daily thereafter.
Managed with oral meds at home, but these were held while in the hospital.
FS were in high 200's here, so pt was started on low-dose NPH as well as ISS.
- pt was restarted on oral hypoglycemic on discharge .
#) Pancreatic Cancer: Pt was 2.5 months out from pancreatic surgery for Grade I, T3 N1b adenocarcinoma resection.
- pt will continue on xeloda as an outpatient - pt had final session of XRT to the pancreas during this admission on [**6-8**] (this had been scheduled prior to admission for GI bleed) - pt's abdominal incision from recent surgery was found to have small wound draining brownish fluid.
Pt's surgeon (Dr. [**Last Name (STitle) 468**] was notified, and recommended starting zinc and Vit C to assist healing.
Pt was continued on zinc and Vit C on discharge.
- transfusions were given as above - continued iron - continued vitamin B6, folic acid - pt to receive procrit as an outpatient .
#) Dispo: home  Medications on Admission: Meds (From Discharge in [**3-19**]): ASA 81 qd folic acid 1 tid vit B6 100 tid iron qd allopurinol 300mg qd glipizide 10mg [**Hospital1 **] metformin 500 [**Hospital1 **]   Discharge Medications: 1.
Protonix 40 mg Tablet, Delayed Release (E.C.)
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Pyridoxine 50 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Allopurinol 300 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Zinc Sulfate 220 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Ascorbic Acid 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Glipizide 10 mg Tablet Sig: One (1) Tablet PO twice a day.
Metformin 500 mg Tablet Sig: One (1) Tablet PO twice a day.
Please take all medications as prescribed.
Do not take aspirin unless your PCP or oncologist instructs you to re-start this medication.
